BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 34404545)

  • 21. Infusion of Host-Derived Unlicensed NK Cells Improves Donor Engraftment in Non-Myeloablative Allogeneic Hematopoietic Cell Transplantation.
    Alvarez M; Pierini A; Simonetta F; Baker J; Maas-Bauer K; Hirai T; Negrin RS
    Front Immunol; 2020; 11():614250. PubMed ID: 33488624
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative analysis of chimerism after allogeneic stem cell transplantation by real-time polymerase chain reaction with single nucleotide polymorphisms, standard tandem repeats, and Y-chromosome-specific sequences.
    Koldehoff M; Steckel NK; Hlinka M; Beelen DW; Elmaagacli AH
    Am J Hematol; 2006 Oct; 81(10):735-46. PubMed ID: 16838323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preimplantation genetic testing practices in the Nordic countries.
    Hreinsson J; Iwarsson E; Hanson C; Grøndahl ML; Løssl K; Hydén-Granskog C; Ingerslev HJ;
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):707-715. PubMed ID: 32034767
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Challenges for the standardized reporting of NGS HLA genotyping: Surveying gaps between clinical and research laboratories.
    Osoegawa K; Montero-Martín G; Mallempati KC; Bauer M; Milius RP; Maiers M; Fernández-Viña MA; Mack SJ
    Hum Immunol; 2021 Nov; 82(11):820-828. PubMed ID: 34479742
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced-intensity conditioning hematopoietic cell transplantation is an effective treatment for patients with SLAM-associated protein deficiency/X-linked lymphoproliferative disease type 1.
    Marsh RA; Bleesing JJ; Chandrakasan S; Jordan MB; Davies SM; Filipovich AH
    Biol Blood Marrow Transplant; 2014 Oct; 20(10):1641-5. PubMed ID: 24923536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor Chimerism of B Cells and Nature Killer Cells Provides Useful Information to Predict Hematologic Relapse following Allogeneic Hematopoietic Stem Cell Transplantation.
    Jiang Y; Wan L; Qin Y; Wang X; Yan S; Xie K; Wang C
    PLoS One; 2015; 10(7):e0133671. PubMed ID: 26226104
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The EuroChimerism concept for a standardized approach to chimerism analysis after allogeneic stem cell transplantation.
    Lion T; Watzinger F; Preuner S; Kreyenberg H; Tilanus M; de Weger R; van Loon J; de Vries L; Cavé H; Acquaviva C; Lawler M; Crampe M; Serra A; Saglio B; Colnaghi F; Biondi A; van Dongen JJ; van der Burg M; Gonzalez M; Alcoceba M; Barbany G; Hermanson M; Roosnek E; Steward C; Harvey J; Frommlet F; Bader P
    Leukemia; 2012 Aug; 26(8):1821-8. PubMed ID: 22395360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.
    Koenecke C; Shaffer J; Alexander SI; Preffer F; Dombkowski D; Saidman SL; Dey B; McAfee S; Spitzer TR; Sykes M
    Exp Hematol; 2003 Oct; 31(10):911-23. PubMed ID: 14550807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rapid establishment of dendritic cell chimerism in allogeneic hematopoietic cell transplant recipients.
    Auffermann-Gretzinger S; Lossos IS; Vayntrub TA; Leong W; Grumet FC; Blume KG; Stockerl-Goldstein KE; Levy R; Shizuru JA
    Blood; 2002 Feb; 99(4):1442-8. PubMed ID: 11830498
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Digital droplet PCR-based chimerism analysis for monitoring of hematopoietic engraftment after allogeneic stem cell transplantation.
    Mika T; Baraniskin A; Ladigan S; Wulf G; Dierks S; Haase D; Schork K; Turewicz M; Eisenacher M; Schmiegel W; Schroers R; Klein-Scory S
    Int J Lab Hematol; 2019 Oct; 41(5):615-621. PubMed ID: 31225701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Practice patterns and incidence of adenovirus infection in allogeneic hematopoietic cell transplant recipients: Multicenter survey of transplant centers in the United States.
    Papanicolaou GA; Dvorak CC; Dadwal S; Maron G; Prasad VK; Giller R; Abdel-Azim H; Sadanand A; Casciano R; Chandak A; Huang S; Nichols G; Brundage T; Vainorius E; Mozaffari E; Hutcheson R
    Transpl Infect Dis; 2020 Aug; 22(4):e13283. PubMed ID: 32267590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of impending graft rejection and relapse by lineage-specific chimerism analysis.
    Lion T
    Methods Mol Med; 2007; 134():197-216. PubMed ID: 17666752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid single nucleotide polymorphism based method for hematopoietic chimerism analysis and monitoring using high-speed droplet allele-specific PCR and allele-specific quantitative PCR.
    Taira C; Matsuda K; Yamaguchi A; Uehara M; Sugano M; Okumura N; Honda T
    Clin Chim Acta; 2015 May; 445():101-6. PubMed ID: 25797898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Donor Chimerism Threshold for Next-Generation Sequencing Monitoring of Measurable Residual Disease Post-Allogeneic Stem Cell Transplantation for Myeloid Neoplasms.
    Puzo CJ; Tormey CA; Rinder HM; Siddon AJ
    Transplant Cell Ther; 2023 Jul; 29(7):459.e1-459.e4. PubMed ID: 37062510
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chimerism in pediatric hematopoietic stem cell transplantation and its correlation with the clinical outcome.
    Gabr H; Youssry I; El-Ansary Y; Mosallam G; Riad NM; Hanna MOF
    Transpl Immunol; 2017 Dec; 45():53-58. PubMed ID: 28951259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of an algorithm of satellite markers for monitoring chimerism status in post-allogeneic haematopoietic stem cell transplantation patients.
    Choong SS; Rosmanizam S; Ibrahim K; Gan GG; Ariffin H
    Int J Lab Hematol; 2011 Apr; 33(2):182-6. PubMed ID: 20868447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of chimerism analysis after allogeneic stem cell transplantation: Belgian guidelines and review of the current literature.
    Delie A; Verlinden A; Beel K; Deeren D; Mazure D; Baron F; Breems D; De Becker A; Graux C; Lewalle P; Maertens J; Poire X; Schoemans H; Selleslag D; Van Obbergh F; Kerre T
    Acta Clin Belg; 2021 Dec; 76(6):500-508. PubMed ID: 32362204
    [No Abstract]   [Full Text] [Related]  

  • 38. Therapeutic and diagnostic applications of minor histocompatibility antigen HA-1 and HA-2 disparities in allogeneic hematopoietic stem cell transplantation: a survey of different populations.
    Di Terlizzi S; Zino E; Mazzi B; Magnani C; Tresoldi C; Perna SK; Bregni M; Rossini S; Ciceri F; Bordignon C; Bonini C; Fleischhauer K
    Biol Blood Marrow Transplant; 2006 Jan; 12(1):95-101. PubMed ID: 16399573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In situ activation and expansion of host tregs: a new approach to enhance donor chimerism and stable engraftment in major histocompatibility complex-matched allogeneic hematopoietic cell transplantation.
    Shatry A; Levy RB
    Biol Blood Marrow Transplant; 2009 Jul; 15(7):785-94. PubMed ID: 19539209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A SYBR green-based real-time PCR method for detection of haemopoietic chimerism in allogeneic haemopoietic stem cell transplant recipients.
    Bai L; Deng YM; Dodds AJ; Milliken S; Moore J; Ma DD
    Eur J Haematol; 2006 Nov; 77(5):425-31. PubMed ID: 16899058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.